{"id":47795,"date":"2012-06-19T19:22:47","date_gmt":"2012-06-19T19:22:47","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/cryopraxis-sponsor-of-stem-cell-research-is-represented-at-bio2012-in-boston.php"},"modified":"2012-06-19T19:22:47","modified_gmt":"2012-06-19T19:22:47","slug":"cryopraxis-sponsor-of-stem-cell-research-is-represented-at-bio2012-in-boston","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/cryopraxis-sponsor-of-stem-cell-research-is-represented-at-bio2012-in-boston.php","title":{"rendered":"Cryopraxis, Sponsor of Stem Cell Research is Represented at Bio2012 in Boston"},"content":{"rendered":"<p><p>      RIO DE JANEIRO--(BUSINESS WIRE)--    <\/p>\n<p>      Cryopraxis established in 2001 as the pioneer private      umbilical cord blood bank in Brazil will be present at Bio      2012 in Boston. Eduardo Cruz, chairman of the board, will be      a speaker at the Brazilian break-out session speaking about      The Brazilian Biotechnology Sector and showing the results of      the company's commitment to R&D. Cryopraxis has already      collected and processed more than 25000 cord blood units      (CBU) and is actively involved in several R&D projects in      Brazil and abroad.    <\/p>\n<p>      A spin-off of Cryopraxis, Cellpraxis, has recently finished      one of the world's first cell therapy project clinical trials      in Brazil: ReACT. ReACT is a stem cell formulation. This      regenerative medicine pioneer product aims on treating an      orphan disease condition called refractory angina. Refractory      angina patients suffer from untreatable severe chest pain and      the results of the clinical trial in a 5 years follow up      proved ReACT to positively interfere in the course of the      pathology. Most of the individuals treated experienced relief      in pain and better quality of life. ReACT will be presented      at Bio2012 as an example of Brazil's dynamic biotechnology      research.    <\/p>\n<p>      Cryopraxis is accredited by the American Association of Blood      Bank since 2009.    <\/p>\n<p>      According to Tatiana Lima, Technical Director at Cryopraxis,      \"extensive training and strict adherence to good laboratory      practices are basic principles in Cryopraxis' corporate      strategy.\" Janaina Machado, cell lab director describes the      company's primary mission: \"maximizing safety and efficiency      of collection procedures to make sure our clients get what      they look for: the highest quality standards.\"    <\/p>\n<p>      Cryopraxis is part of Axis Biotec (www.axisbiotec.com.br)      and it has the largest biological cryogenic storage facility      in Brazil and one of the largest in the World. It is the      largest umbilical cord blood bank in Brazil. The company is      involved in several research projects in Brazil and      abroad.For more information, visitwww.cryopraxis.com.brand            <a href=\"http:\/\/www.cellpraxis.com\" rel=\"nofollow\">http:\/\/www.cellpraxis.com<\/a>    <\/p>\n<\/p>\n<p>Excerpt from: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/cryopraxis-sponsor-stem-cell-research-153700022.html;_ylt=A2KJjal90eBPkB4AsWX_wgt.\" title=\"Cryopraxis, Sponsor of Stem Cell Research is Represented at Bio2012 in Boston\">Cryopraxis, Sponsor of Stem Cell Research is Represented at Bio2012 in Boston<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> RIO DE JANEIRO--(BUSINESS WIRE)-- Cryopraxis established in 2001 as the pioneer private umbilical cord blood bank in Brazil will be present at Bio 2012 in Boston. Eduardo Cruz, chairman of the board, will be a speaker at the Brazilian break-out session speaking about The Brazilian Biotechnology Sector and showing the results of the company's commitment to R&#038;D. Cryopraxis has already collected and processed more than 25000 cord blood units (CBU) and is actively involved in several R&#038;D projects in Brazil and abroad <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/cryopraxis-sponsor-of-stem-cell-research-is-represented-at-bio2012-in-boston.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-47795","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47795"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=47795"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/47795\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=47795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=47795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=47795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}